These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3620006)

  • 21. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
    Han P; Boatwright C; Ardlie NG
    Thromb Haemost; 1983 Aug; 50(2):513-7. PubMed ID: 6314581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of 1-(3-chloroanilino)-4-phenylphthalazine (MY-5445), a specific inhibitor of cyclic GMP phosphodiesterase, on human platelet aggregation.
    Hagiwara M; Endo T; Kanayama T; Hidaka H
    J Pharmacol Exp Ther; 1984 Feb; 228(2):467-71. PubMed ID: 6141286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of human platelet functions by verapamil.
    Ikeda Y; Kikuchi M; Toyama K; Watanabe K; Ando Y
    Thromb Haemost; 1981 Apr; 45(2):158-61. PubMed ID: 6789494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of tris on responses of human and rabbit platelets to aggregating agents.
    Packham MA; Guccione MA; Nina M; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1984 Apr; 51(2):140-4. PubMed ID: 6429880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acidic peptides enhanced genistein-dependent inhibition of human platelet aggregation: potential protective effect of digestible peptides plus genistein against atherosclerosis.
    Borgwardt K; Bonifatius S; Gardemann A
    Nutr Res; 2008 Aug; 28(8):523-31. PubMed ID: 19083455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin.
    Storey RF; May JA; Heptinstall S
    Thromb Res; 2005; 115(4):301-7. PubMed ID: 15668190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of platelet function of antiarrhythmic drugs, verapamil and disopyramide.
    Han P; Boatwright C; Ardlie NG
    Thromb Haemost; 1982 Apr; 47(2):150-3. PubMed ID: 7101234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of human and rat platelet aggregation by extracts of Mo-er (Auricularia auricula).
    Agarwal KC; Russo FX; Parks RE
    Thromb Haemost; 1982 Oct; 48(2):162-5. PubMed ID: 6983740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro effect of ethanol on ADP and collagen-induced platelet aggregation.
    Bengmark S; Elmér O; Göransson G; Zoucas E
    Thromb Haemost; 1981 Dec; 46(4):673-5. PubMed ID: 7330816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
    Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
    Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of adrenergic neuron blocking agents on the adrenaline-induced platelet reactions.
    Glusa E; Markwardt F
    Acta Biol Med Ger; 1982; 41(6):565-9. PubMed ID: 6128849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of chronic treatment with adrenaline or propranolol on platelet function and c-AMP levels in the rat.
    Terres W; Becker BF; Schrödl W; Gerlach E
    Cardiovasc Res; 1989 Feb; 23(2):112-6. PubMed ID: 2550130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of human tumor cells on platelet aggregation: potential relevance to pattern of metastasis.
    Mehta P; Lawson D; Ward MB; Kimura A; Gee A
    Cancer Res; 1987 Jun; 47(12):3115-7. PubMed ID: 3472652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies on platelet aggregation inhibitory agents (author's transl)].
    Ukita M; Kitahara T; Hosokawa T; Kato M; Suzuki Y; Otomo H
    Nihon Ketsueki Gakkai Zasshi; 1974 Apr; 37(2):161-5. PubMed ID: 4369675
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative effects of β-carbolines on platelet aggregation and lipid membranes.
    Tsuchiya H; Ohmoto S
    Pharmacol Rep; 2010; 62(4):689-95. PubMed ID: 20885009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proceedings: The effect on benzcyclan and theophyllin on the ADP induced platelet aggregation in vitro and vivo.
    Losonczy H; Nagy I; Gregus Z; Szaksz I
    Thromb Diath Haemorrh; 1975 Sep; 34(1):336. PubMed ID: 1188766
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of metoprolol and propranolol on platelet aggregation and cAMP level in hypertensive patients.
    Winther K; Knudsen JB; Gormsen J; Jensen J
    Eur J Clin Pharmacol; 1986; 29(5):561-4. PubMed ID: 3007163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet aggregation and atrial natriuretic peptide.
    Ulker S; Akgür S; Evinç A; Soykan N; Koşay S
    Gen Pharmacol; 1995 Oct; 26(6):1409-12. PubMed ID: 7590139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of acetaldehyde on rat platelet aggregation in vivo and in vitro.
    Zoucas E; Bengmark S
    Res Exp Med (Berl); 1987; 187(1):43-8. PubMed ID: 3575882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.